GFM
EW icon

GF Fund Management’s Edwards Lifesciences EW Stock Holding History

GF Fund Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Hold
15,919
– – 0.02% 181
2025
Q4 		$1.36M Sell
15,919
-299
-2% -$24.5K 0.02% 184
2025
Q3 		$1.26M Buy
16,218
+2,735
+20% +$214K 0.02% 187
2025
Q2 		$1.05M Sell
13,483
-100
-0.7% -$7.46K 0.02% 208
2025
Q1 		$984K Hold
13,583
– – 0.02% 203
2024
Q4 		$1.01M Buy
+13,583
New +$951K 0.02% 200

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GF Fund Management's EW Position: Q1 2026 in Review

GF Fund Management held its Edwards Lifesciences (EW) position steady in Q1 2026 at 15,919 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #181.

GF Fund Management first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.36M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • GF Fund Management held 15,919 shares of Edwards Lifesciences worth $1.27M as of Q1 2026.
  • GF Fund Management left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.02% of GF Fund Management's portfolio in Q1 2026, its #181 holding.
  • GF Fund Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Edwards Lifesciences position peaked at $1.36M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.